Clinicopathologic characteristics and treatment outcome of the addition of rituximab to chemotherapy for CD5-positive in comparison with CD5-negative diffuse large B-cell lymphoma

N. Niitsu, M. Okamoto, J. I. Tamaru, T. Yoshino, N. Nakamura, S. Nakamura, K. Ohshima, H. Nakamine, M. Hirano

Research output: Contribution to journalArticlepeer-review

51 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Clinicopathologic characteristics and treatment outcome of the addition of rituximab to chemotherapy for CD5-positive in comparison with CD5-negative diffuse large B-cell lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences